title: Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders.
abstract: BACKGROUND
  Although quetiapine has often been used as monotherapy or adjunctive therapy in bipolar disorder, there is very limited clinical evidence regarding prescribing practices for quetiapine as maintenance treatment for bipolar disorder.
  
  
  METHODS
  We reviewed the inpatient and outpatient records of 175 Chinese patients who received treatment with quetiapine for bipolar disorder both during and following hospitalization. We compared patients treated with high-dose (>300 mg/day) and low-dose (≤300 mg/day) quetiapine during the acute treatment phase and in the subsequent 6 months of maintenance treatment, with assessments at months 1, 3, and 6. Multifactor logistic regression analysis was performed to identify factors associated with quetiapine dosage.
  
  
  RESULTS
  The proportion of patients receiving combination therapy of quetiapine and a mood stabilizer as acute and maintenance treatment was 99.4% and 84.6%, respectively. The mean dose of quetiapine when used for acute treatment in the 175 patients was 395.7 mg/day. The following factors were found to be independently associated with use of high-dose quetiapine: male gender (odds ratio [OR] 2.712, 95% confidence interval [CI] 1.372-5.362, P < 0.01), a manic or mixed episode (OR 2.786, 95% CI 1.362-5.699, P < 0.01), and psychotic features (OR 2.658, 95% CI 1.318-5.361, P < 0.01). In the subsequent 6 months, the mean dose of quetiapine prescribed steadily decreased to 375.0 mg/day, 330.6 mg/day, and 293.7 mg/day at months 1, 3, and 6. The main factors associated with high-dose quetiapine in maintenance treatment were male gender (month 1, OR 2.761; month 3, OR 2.583; month 6, OR 2.686; P < 0.01) and a manic or mixed episode (month 1, OR 2.626; month 3, OR 2.334; P < 0.01).
  
  
  CONCLUSIONS
  Higher doses of quetiapine (>300 mg/day) are more likely to be prescribed to patients who are male, those who are experiencing a manic or mixed episode, and those who have psychotic features during acute treatment of bipolar disorder. For patients who remain clinically stable during the subsequent months, the quetiapine dose should be adjusted according to patient gender and the most recent type of episode experienced.
authors: Mood Disorders Center, Beijing Anding Hospital, Capital Medical University, Beijing, People's Republic of China.
authors: Ling
authors: L
authors: Zhang
authors: Gang
authors: G
authors: Wang
authors: Jiong
authors: J
authors: Luo
authors: Qing-E
authors: QE
authors: Zhang
authors: Qian
authors: Q
authors: Zhao
authors: Qi-Ying
authors: QY
authors: Deng
authors: Xin
authors: X
authors: Ma
keywords: acute treatment; bipolar disorder; dosage; maintenance treatment; quetiapine
references: Neuropsychiatr Dis Treat. 2006 Jun;2(2):139-48
references: 19412458
references: Eur Neuropsychopharmacol. 2005 Oct;15(5):573-85
references: 16139175
references: Am J Psychiatry. 2005 Jul;162(7):1351-60
references: 15994719
references: J Affect Disord. 2003 Sep;76(1-3):267-71
references: 12943958
references: Int J Psychiatry Clin Pract. 2001;5(4):283-5
references: 24921697
references: J Clin Psychiatry. 2005 Jan;66(1):111-21
references: 15669897
references: J Affect Disord. 2008 Sep;110(1-2):135-41
references: 18329720
references: Bipolar Disord. 2004 Jun;6(3):213-23
references: 15117400
references: J Affect Disord. 2008 Jan;105(1-3):305-10
references: 17550787
references: J Psychiatr Res. 2010 Oct;44(14):921-9
references: 20378127